HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches.
about
Ratiometric spectral imaging for fast tumor detection and chemotherapy monitoring in vivo.Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.Multimode Optical Imaging for Translational Chemotherapy: In Vivo Tumor Detection and Delineation by Targeted Gallium CorrolesTargeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONsBiological rationale for the design of polymeric anti-cancer nanomedicines.Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancerMolecular-targeted nanotherapies in cancer: enabling treatment specificity.Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Promising iron oxide-based magnetic nanoparticles in biomedical engineering.Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo.Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy.Anti-lung cancer activity through enhancement of immunomodulation and induction of cell apoptosis of total triterpenes extracted from Ganoderma luncidum (Leyss. ex Fr.) Karst.Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticlesHighly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles.Stimulated production of triterpenoids of Ganoderma lucidum by an ether extract from the medicinal insect, Catharsius molossus, and identification of the key stimulating active components.Improving the fermentation production of the individual key triterpene ganoderic acid me by the medicinal fungus Ganoderma lucidum in submerged culture.Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.Oxygen limitation improves ganoderic acid biosynthesis in submerged cultivation of Ganoderma lucidumRecovery of ganoderic acids from Ganoderma lucidum mycelia by macroporous adsorption resinsWhat Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future
P2860
Q35097854-87A058B4-FA7A-44CD-8451-784E6A97CE72Q35558487-5A6E6371-287D-4D4F-8FF7-9DE75C5B32E7Q36092086-B95E2B30-8784-4304-9C37-3640AEA51DD1Q36096040-8785C104-B3CD-49FA-B830-9084DA6AA0BAQ36160333-2015224D-C49C-45C7-9AE2-20D30FB0B9DDQ36381340-802200BC-FEB2-4D7B-BDFC-31CBFE4675D6Q37225532-80084DA1-7C5D-4539-978B-7BDEA2EC7CB5Q37954497-058DC32C-AA97-408F-9CB7-3F35358C3BDAQ37957956-E3C72365-F477-45EA-8145-D78AE3FA72BEQ38069511-DDC1DA76-81E0-46AA-A7E6-82860C4AACCFQ38136246-B529FDDF-C8CF-4734-AF2F-B06618524982Q38206265-94A83EAC-549C-4FF0-B810-0A93928D424DQ38382577-8A0A76A4-19ED-415A-AF39-0807D66557E8Q38852051-F123A40F-6B7F-408D-A397-A8DC1C49612AQ38904163-7C5C8653-2D42-43AD-95DC-0CCBC214AAECQ39107023-43595A4C-2870-4FA3-B535-E01222ABB503Q39219446-9A93E01F-EE8A-4DBF-80A4-B4984FC591AAQ39549391-259FAE49-F573-4BA1-83B4-EB6374867607Q39650591-F1A7A167-37EA-4DA7-8800-BA9188E318B8Q48273492-8E1291C9-333C-43F6-8BE0-83013A604F99Q51306768-7884210D-EB7A-448A-926A-E178FCA5F4E5Q54921136-E6CF8392-ADD8-4836-85AC-D296ABAFB407Q57699786-A0BAD7F3-B79F-42E7-816E-975151B2CEC2Q57699829-0B012421-774F-472F-9AC2-EE0649CFC6D2Q59128232-E9B20AA5-BFB2-45F4-A56E-8674C2A4565C
P2860
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@en
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@nl
type
label
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@en
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@nl
prefLabel
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@en
HER2 targeting as a two-sided ...... ons in nanomedical approaches.
@nl
P2093
P50
P1476
HER2 targeting as a two-sided ...... ions in nanomedical approaches
@en
P2093
Davide Prosperi
Elisa Mazzantini
Emanuela Occhipinti
Paolo Verderio
Silvia Ronchi
P304
P356
10.1016/J.PHRS.2010.01.013
P577
2010-02-01T00:00:00Z